Approval was linked to a 36% increase in vaccinations, but most of these were 2nd doses. They found 1st doses were actually 16% lower than predicted.
Some hoped FDA approval of Pfizer’s COVID vaccine would convince unvaccinated Americans. It didn’t, study finds.
